Hazard Hub

Product quality Recalls in Canada — Page 3

347 recalls involving product quality — most are health products recalls. Newest first, updated daily from government open data.

Showing 61–90 of 347

Health Products Type II
2025-12-05

Mucus & Phlegm relief extra strength: may have been exposed to temperatures outside of the recommended storage conditions

Product quality

View recall details →

Health Products Type II
2025-12-01

ERYTHROMYCIN OPHTHALMIC OINTMENT USP: Sterility Concerns

Product quality

View recall details →

Health Products Type II
2025-11-24

Extra Strength Ibuprofen Liquid Gel Capsules: Presence of cloudy capsules in affected lots

Product quality

View recall details →

Health Products Type III
2025-11-20

PMS-QUETIAPINE: Out of Specification

Product quality

View recall details →

Health Products Type III
2025-11-19

JAMP-Risperidone 0.25mg: Out of specification (Stability)

Product quality

View recall details →

Health Products Type II
2025-11-13

Septodont Products: Cracked glass cartridges

Product quality

View recall details →

Health Products Type II
2025-11-10

FOLLTROPIN-V : affected lots may contain particulate matter

Product quality

View recall details →

Health Products Type II
2025-11-07

DEXMEDETOMIDINE HYDROCHLORIDE FOR INJECTION, USP: Out of Specification Test Result

Product quality

View recall details →

Health Products Type II
2025-10-31

Ozempic Solution: Cracked glass cartridges

Product quality

View recall details →

Health Products Type II
2025-10-08

Lisinopril HCT 20/25mg: Out-of-specification test results

Product quality

View recall details →

Health Products Type II
2025-09-26

Amlodipine 10 mg tablet; Oversized tablets

Product quality

View recall details →

Health Products Type II
2025-09-23

Jamp-Senna 8.6 mg tablet; Out of Specification (Total yeast & mold count; total aerobic microbiological count)

Product quality

View recall details →

Health Products Type III
2025-09-23

MAG Trio capsules; Incorrect NPN & may contain magnesium levels outside labelled claim

Product quality

View recall details →

Health Products Type II
2025-09-08

Kids by Babyganics SPF 50 Mineral Sunscreen Totally Tropical (rollerball and continuous spray formulas): Impurity

Product quality

View recall details →

Health Products Type III
2025-09-08

Sunforce Health & Organics products recall; Deficiencies in Good Manufacturing Practices

Product quality

View recall details →

Health Products Type III
2025-09-08

NazalActin Liquid: No market authorization, incorrect NPN, deficiencies in Good Manufacturing Practices

Product quality

View recall details →

Other
2025-09-05

Kids by Babyganics SPF 50 Mineral Sunscreen Totally Tropical (rollerball and continuous spray formulas)

Product quality

View recall details →

Health Products Type III
2025-09-02

PMS-Busulfan 6 mg/mL; Out of specification (Impurities)

Product quality

View recall details →

Health Products Type II
2025-08-29

PMS-SUMATRIPTAN: may not contain the correct amount of tablets (empty blister packs)

Product quality

View recall details →

Health Products Type III
2025-08-15

Wellness by London Drugs Hand Sanitizer Gel; Deficiencies in Good Manufacturing Practices

Product quality

View recall details →

Health Products Type II
2025-08-13

Jamp Bisoprolol 5 mg tablet: may contain a foreign tablet

Product quality

View recall details →

Health Products Type II
2025-07-29

Fucidin tablet: Out of specification

Product quality

View recall details →

Health Products Type II
2025-07-23

Apo-Lisdexamfetamine 30mg : may contain broken capsules and/or loose capsule content.

Product quality

View recall details →

Health Products Type I
2025-07-16

Mylan-Cinacalcet: Affected lots exceed the established acceptable intake limit for N-nitroso-cinacalcet.

Product quality

View recall details →

Health Products Type I
2025-07-11

Taro-Doxorubicin Liposomal: may contain particulate matter

Product quality

View recall details →

Health Products Type II
2025-07-10

Apo-Dutasteride 0.5 mg: Affected lot may contain undersized capsules

Product quality

View recall details →

Health Products Type II
2025-07-07

Anesketin : Presence of particulate matter in the affected lots

Product quality

View recall details →

Health Products Type I
2025-07-04

PMS-Methylphenidate CR 10 mg capsule; exceed the acceptable intake limit for N-nitroso-methylphenidate

Product quality

View recall details →

Health Products Type I
2025-07-03

RIVA-Fluoxetine 10 mg capsule; may exceed the interim acceptable intake limit for N-nitroso-fluoxetine

Product quality

View recall details →

Health Products Type I
2025-06-30

PMS-Fluoxetine 10 mg capsule; may exceed the interim acceptable intake limit for N-nitroso-fluoxetine

Product quality

View recall details →

Other Health Products Hazards

COVID (276)Labelling (71)Contamination (64)Packaging (46)

Browse all recalls by hazard, allergen & year →